Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in TCRX — TScan Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$16,128
-$471 QoQ
Shares Held
16,458
+0.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 60 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. TCRX ranks #332 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in TCRX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,128 16,458
2026-03-31 $16,599 16,436
2025-12-31 $33,349 33,349
2025-09-30 $432,704 237,750
2025-06-30 $417,226 287,743
2025-03-31 $365,837 265,101
2024-12-31 $202,937 66,756
2024-09-30 $158,388 31,805
2024-06-30 $95,729 16,364
2024-03-31 $532,083 67,013
2023-12-31 $193,730 33,230
2022-03-31 $1,010 361